Invokamet FAQ
What is Invokamet? Invokamet contains canagliflozin and metformin, oral diabetes medications that help control blood sugar levels in patients with type 2 diabetes. Canagliflozin works by helping the kidneys expel glucose from the blood through the urine. Invokamet is made by Janssen Pharmaceuticals (a Johnson & Johnson company), and was approved by the U.S. Food […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling Invokamet cases nationwide and you can contact them below. To learn […]
Update: FDA Requires Boxed Warning on Amputation Risk with Invokana May 16, 2017 – Based on the final results of 2 long-term clinical trials, FDA has concluded that type 2 diabetes patients who take Invokana or Invokamet are twice as likely to have their foot or toe amputated. As a result of these findings, the […]
What is Prilosec? Prilosec (generic: omeprazole) is a proton pump inhibitor (PPI) drug that is used to treat certain esophageal problems such as acid reflux and ulcers. The medication works by blocking an enzyme in the wall of the stomach that produces acid. Omeprazole was originally approved by the U.S. Food & Drug Administration (FDA) […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling Prilosec cases nationwide and you can contact them below. To learn […]
Update: Study Finds Increased Risk of Death with PPI Heartburn Medications July 5, 2017 – Proton pump inhibitors have been linked to a 25% greater risk of death compared to patients who took H2 blockers, according to a study published Monday in BMJ. The study also found that PPI use was linked to a 15% […]
What is an IVC Filter? Inferior vena cava (IVC) filters are small, cone-shaped medical devices that are inserted into the inferior vena cava just below the kidneys. The filters are designed to capture blood clots that have broken loose from one of the deep veins in the legs before they reach the heart and lungs. […]
Get Help Now Prescription Drug Journal is sponsored by Schmidt & Clark, LLP. The law firm firm is recognized as “One of The Nation’s Leading Law Firms” and has been helping America’s injured individuals and families since 1992. Schmidt & Clark, LLP is handling IVC filter cases nationwide and you can contact them below. To […]
What’s the Problem? Retrievable inferior vena cava (IVC) filters are implanted into the veins of patients who are unable to take blood thinner medications in order to prevent blood clots from traveling to the lungs (pulmonary embolism). The devices intercept clots in the bloodstream and, over time, the clots break down. However, the U.S. Food […]
What is Invokana? Invokana (generic: canagliflozin) is used to control blood sugar levels in patients with type 2 diabetes. The drug works by increasing the removal of sugar through the kidneys. Invokana is a member of a new class of type 2 diabetes drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors, which also includes Invokamet (canagliflozin […]